The Faculty of Medicine is pleased to announce the successful applicants of the 2024 Path to Patenting & Pre-commercialization (3P) Grant competition. The Path to Patenting & Pre-commercialization grant program helps move early-stage biomedical research from the lab toward real-world applications by supporting proof-of-concept studies and commercialization efforts. It provides funding for key experiments, intellectual property protection, market assessments, and business development to help researchers bring their innovations to market.
Together with the Ottawa Hospital Research Institute (OHRI), the University of Ottawa Heart Institute (UOHI), the Children’s Hospital of Eastern Ontario Research Institute (CHEO RI), the Bruyère Health Research Institute (BHRI), the Brain-Heart Interconnectome (BHI) and uOttawa’s Innovation Support Services, we wish to congratulate the 2024 recipients as they take the next steps toward bringing their discoveries to market:
- Tommy Alain (CHEO RI/BMI): ‘Viral 5’UTRs that enhance translation of transgenes from oncolytic HSV1, and method of identifying and screening thereof’
- Angela Cheung (OHRI/Medicine): ‘Artificial intelligence models for early detection of hepatocellular carcinoma’
- Andrew Frank (BHRI/BHI/Medicine): ‘Development of an artificial intelligence-driven virtual companion for people living with dementia’
- Calum Redpath (UOHI/Medicine): ‘Precision treatment planning software for ventricular arrhythmia localization’